← Back to Search

Other

Low-level laser for Lymphedema

N/A
Waitlist Available
Research Sponsored by Abramson Cancer Center at Penn Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8-week post-lllt
Awards & highlights

Study Summary

This trial will study whether low-level laser treatment can help improve symptoms, quality of life, and functional status in head and neck cancer survivors with lymphedema.

Eligible Conditions
  • Lymphedema
  • Fibrosis
  • Head and Neck Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8-week post-lllt
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8-week post-lllt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
% of patients with reduced severity of lymphedema and fibrosis
Secondary outcome measures
Neck
Quality of life score
Symptom burden score

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1 (laser group)Experimental Treatment1 Intervention
Group 1 (laser group): After completion of the baseline measurements, Group 1 participants will be scheduled for LLLT. After completion of LLLT, participants will be scheduled for the 4-week and 8-week follow up data collection.
Group II: Group 2 (wait-list control group)Active Control1 Intervention
Group 2 (wait-list control group): Group 2 participants will not undergo LLLT therapy but will complete all the same study assessments as the laser therapy group, including the baseline, and follow-up assessments. After the 8-week follow-up assessment, participants will be offered the same LLLT as the laser group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-level laser
2020
N/A
~230

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
145,669 Total Patients Enrolled
3 Trials studying Lymphedema
564 Patients Enrolled for Lymphedema
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,880,062 Total Patients Enrolled
3 Trials studying Lymphedema
371 Patients Enrolled for Lymphedema

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to join this investigation?

"The details recorded on clinicaltrials.gov state that this study is actively looking for participants, and it was initially advertised in August 2021 with the latest modifications made in September 2022."

Answered by AI

What is the current enrollment size for this research endeavor?

"Affirmative. Clinicaltrials.gov indicates that this clinical study, which was first posted on August 19th 2021, is actively seeking participants. The trial requires 30 individuals from 1 medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
Delaware
How old are they?
18 - 65
What site did they apply to?
University of Pennsylvania Abramson Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I had Melanoma on my foot and have lymphedma on left leg. Had sugery at U of P in 2003. Please I am having trouble walking and I am in pain.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Low-Level Laser in Head and Neck Chronic Lymphedema
Jie Deng 2021. "Low-Level Laser in Head and Neck Chronic Lymphedema". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04482855.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top